VVOS
NASD Vivos Therapeutics, Inc.$0.1478 ↓ -0.0012 (-0.81%) Trading Down from the previous close of $0.1490, and at the day’s high of $0.1519
- YTD change
- -92.72%
- vs 20-day SMA
- -9.72%
- vs 200-day SMA
- -84.60%
Price ranges
Price & Performance
-1.15 (-88.62%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 100.0% away from all-time highs of $360.2500
- VVOS is down 93% since the beginning of the year
- VVOS is down 95% over the past 12 months
- VVOS is down 12% over the past 1 month
- 9% of all VVOS investors are betting against VVOS
VVOS reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -95.4%.
- Previous minute
- -$0.0030
- Last hour
- -$0.0025
- Last 5 days
- -0.74%
- vs 8-day SMA
- -0.16%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Vivos Therapeutics, Inc. is a medical technology company which engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing (SDB). Its solutions are also offered for patients with mild-to-moderate obstructive sleep apnea (OSA). The company was founded by Gurdev Dave Singh, Susan McCullough, RaeAnn Byrnes, Todd Huntsman, and R. Kirk Huntsman on July 7, 2016 and is headquartered in Littleton, CO.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.